Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDValion Bio Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/14/2026 | Q4 2026 | N/A | -$0.02 | N/A | N/A | $915.38 K |
| 11/14/2025 | Q2 2026 | N/A | -$0.01 | N/A | N/A | $778.77 K |
| 11/15/2021 | Q2 2022 | N/A | -$0.01 | N/A | N/A | $0 |
| 08/13/2021 | Q1 2022 | N/A | -$0.01 | N/A | N/A | $0 |
| 05/19/2021 | Q4 2021 | N/A | -$0.01 | N/A | N/A | $0 |
| 01/29/2021 | Q3 2021 | N/A | $0.01 | N/A | N/A | $0 |
| 11/13/2020 | Q2 2021 | N/A | -$0.01 | N/A | N/A | $0 |
| 08/14/2020 | Q1 2021 | N/A | -$0.01 | N/A | N/A | $0 |
| 06/29/2020 | Q4 2020 | N/A | -$0.01 | N/A | N/A | $0 |
| 02/14/2020 | Q3 2020 | N/A | -$0.02 | N/A | N/A | $0 |
| 11/14/2019 | Q2 2020 | N/A | -$0.02 | N/A | N/A | $0 |
| 08/13/2019 | Q1 2020 | N/A | -$0.03 | N/A | N/A | $0 |
| 07/15/2019 | Q4 2019 | N/A | -$0.32 | N/A | N/A | $0 |
| 02/14/2019 | Q3 2019 | N/A | -$0.04 | N/A | N/A | $0 |
| 11/14/2018 | Q2 2019 | N/A | -$0.05 | N/A | N/A | $0 |
| 08/14/2018 | Q1 2019 | N/A | -$0.04 | N/A | N/A | $0 |
| 06/28/2018 | Q4 2018 | N/A | -$0.04 | N/A | N/A | $30.00 K |
| 02/14/2018 | Q3 2018 | N/A | -$0.05 | N/A | N/A | $20.00 K |
| 11/14/2017 | Q2 2018 | N/A | -$0.04 | N/A | N/A | $30.00 K |
| 08/10/2017 | Q1 2018 | N/A | -$0.05 | N/A | N/A | $30.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Valion Bio Inc. Earnings: FAQ's
The conference call for Valion Bio Inc.'s latest earnings report can be listened to online.
The conference call transcript for Valion Bio Inc.'s latest earnings report can be read online.
Valion Bio Inc. (:VBIO) has a recorded net income of $-880,851.Valion Bio Inc. has generated $-0.0173 earnings per share over the last four quarters.
Valion Bio Inc. (:VBIO) has a price-to-earnings ratio of 3.71 and price/earnings-to-growth ratio is 0.